The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial

被引：0
|
作者：
Krithika Rajagopalan
Elizabeth Dansie Bacci
Kathleen W. Wyrwich
Andrei Pikalov
Antony Loebel
机构：
[1] Sunovion Pharmaceuticals Inc.,
[2] Evidera,undefined
[3] Sunovion Pharmaceuticals Inc.,undefined
[4] Evidera,undefined
来源：
International Journal of Bipolar Disorders | / 4卷
关键词：
Sheehan disability scale; Patient functioning; Bipolar disorder; Depression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial
    Rajagopalan, Krithika
    Bacci, Elizabeth Dansie
    Wyrwich, Kathleen W.
    Pikalov, Andrei
    Loebel, Antony
    INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2016, 4
  • [2] Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
    Loebel, Antony
    Cucchiaro, Josephine
    Silva, Robert
    Kroger, Hans
    Hsu, Jay
    Sarma, Kaushik
    Sachs, Gary
    AMERICAN JOURNAL OF PSYCHIATRY, 2014, 171 (02): : 160 - 168
  • [3] Improvement in anxiety symptoms in bipolar depression with quetiapine monotherapy: Results from two placebo-controlled studies
    Macfadden, W.
    Lydiard, R. B.
    Culpper, L.
    Raines, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S238 - S238
  • [4] Symptom improvement associated with lurasidone treatment of children and adolescents with bipolar I depression: Results of a short-term placebo-controlled trial
    Singh, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S79 - S80
  • [5] Symptom improvement associated with lurasidone treatment of children and adolescents with bipolar I depression: results of a short-term placebo-controlled trial
    Singh, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 66 - 66
  • [6] SYMPTOM IMPROVEMENT ASSOCIATED WITH LURASIDONE TREATMENT OF CHILDREN AND ADOLESCENTS WITH BIPOLAR I DEPRESSION: RESULTS OF A SHORT-TERM PLACEBO-CONTROLLED TRIAL
    Singh, Manpreet K.
    Goldman, Robert
    Tocco, Michael
    Pikalov, Andrei A.
    Deng, Ling
    Cucchiaro, Josephine
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S271 - S272
  • [7] Lurasidone monotherapy in the treatment of bipolar I depression: Efficacy Results of a randomized, double-blind, placebo-controlled, 6-week elevate study
    Kato, T.
    Ishigooka, J.
    Masuda, T.
    Watabe, K.
    Fujimori, T.
    Higuchi, T.
    BIPOLAR DISORDERS, 2019, 21 : 131 - 131
  • [8] Efficacy and safety of lurasidone in bipolar depression: results from two, double blind, placebo-controlled studies
    Loebel, A.
    Cucchiaro, J.
    Silva, R.
    Sarma, K.
    Kroger, H.
    Calabrese, J.
    Sachs, G.
    Grossman, F.
    Pikalov, A.
    BIPOLAR DISORDERS, 2014, 16 : 131 - 132
  • [9] EFFICACY OF LURASIDONE IN BIPOLAR DEPRESSION: RESULTS FROM TWO DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
    Pikalov, A.
    Silva, R.
    Cucchiaro, J.
    Sarma, K.
    Hsu, J.
    Loebel, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 132 - 132
  • [10] Lurasidone monotherapy for the treatment of bipolar I depression: results of a 6-week, double-blind, placebo-controlled study
    Loebel, A.
    Cucchiaro, J.
    Silva, R.
    Sarma, K.
    Kroger, H.
    Calabrese, J. R.
    Sachs, G.
    BIPOLAR DISORDERS, 2013, 15 : 138 - 138
12345